[Solid-state stability and preformulation study of a new parenteral cephalosporin antibiotics (E1040)].

BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.

Cefazaflur, a new parenteral cephalosporin: in vitro studies.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.

In vitro investigation of BK-218, a new oral and parenteral cephalosporin.

Electrochemical analysis of cephalosporin antibiotics.

Metabolic fate of SCE-129, a new antipseudomonal cephalosporin, after parenteral administration in rats and dogs.

Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.

SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.

Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.

In vitro antibacterial activity and beta-lactamase stability of SCE-129, a new cephalosporin.

Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.

In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.

In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.

Cefclidin (E1040), a novel cephalosporin: lack of selection of beta-lactamase overproducing mutants in an in vitro pharmacokinetic model system.

In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa.

tazobactam.

Influence of cephalosporin antibiotics on blood coagulation and platelet function.

In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.

Triazolines. XXI: Preformulation degradation kinetics and chemical stability of a novel triazoline anticonvulsant.

Synthesis and structure-activity relationships of a new series of cephalosporins, E1040 and related compounds.

Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics.

Metabolic fate of [14C]cefamandole, a parenteral cephalosporin antibiotic, in rats and dogs.

Suggest Documents

BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.

Cefazaflur, a new parenteral cephalosporin: in vitro studies.

In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.

Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.

In vitro investigation of BK-218, a new oral and parenteral cephalosporin.

Electrochemical analysis of cephalosporin antibiotics.

Metabolic fate of SCE-129, a new antipseudomonal cephalosporin, after parenteral administration in rats and dogs.

Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.

Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.

SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.

Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.

In vitro antibacterial activity and beta-lactamase stability of SCE-129, a new cephalosporin.

Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.

In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.

In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.

Cefclidin (E1040), a novel cephalosporin: lack of selection of beta-lactamase overproducing mutants in an in vitro pharmacokinetic model system.

In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa.

tazobactam.

Influence of cephalosporin antibiotics on blood coagulation and platelet function.

In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.

Triazolines. XXI: Preformulation degradation kinetics and chemical stability of a novel triazoline anticonvulsant.

Synthesis and structure-activity relationships of a new series of cephalosporins, E1040 and related compounds.

Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics.

Metabolic fate of [14C]cefamandole, a parenteral cephalosporin antibiotic, in rats and dogs.

[Solid-state stability and preformulation study of a new parenteral cephalosporin antibiotics (E1040)].

Recommend Documents

Follow Us